Other

Clinical trials and studies

Natera, Inc. Clinical trials and studies increased by 35.5% to $19.61M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_accrued_clinical_trials_and_studies

Historical Data

2 periods
 Q4 '25Q1 '26
Value$14.47M$19.61M
QoQ Change—+35.5%
Range$14.47M – $19.61M

Frequently Asked Questions

What is Natera, Inc.'s clinical trials and studies?
Natera, Inc. (NTRA) reported clinical trials and studies of $19.61M in Q1 2026.